| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GPR150 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SPATA16 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | PDCD10 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | FGFR1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | ARFGEF3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | KLC1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AL354828.1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | PALM | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | ARHGEF18 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | GSDMA | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
